DUBLIN, Oct. 06, 2017 /PRNewswire/ --

The "Apheresis Equipment - Global Strategic Business Report" report has been added to Research and Markets' offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousand by the following Type of Apheresis Equipment:

• Equipment for Therapeutic Apheresis
• Equipment for Donor Apheresis.

The Global market is additionally analyzed by the following Procedures:

• Photopheresis
• Plasmapheresis
• Others
  

The report profiles 14 companies including many key and niche players such as:

• Asahi Kasei Medical Co., Ltd. (Japan)
• B Braun Melsungen AG (Germany)
• Cerus Corporation (USA)
• Fresenius Kabi (Germany)
• Haemonetics Corporation (USA)
• Kaneka Corporation (Japan)
• Kawasumi Laboratories, Inc. (Japan)
• Mallinckrodt Pharmaceuticals (Ireland)
• Medica SpA (Italy)
• NIKKISO Europe GmbH (Germany)
• Terumo BCT, Inc. (USA)

Key Topics Covered:

1. INDUSTRY OVERVIEW
-  Apheresis Equipment - Rising Adoption of Therapeutic and Donor Apheresis Favors Growth
-  Donor Apheresis & Therapeutic Apheresis
-  Donor Apheresis: Dominating Equipment Sales
-  Therapeutic Apheresis to Witness Strong Growth
-  Disposable Apheresis Kits Market Benefits from Single-Use Nature of Products
-  Centrifugation Technology Continues to Lead, Membrane Filtration Promises Growth
-  Plasmapheresis Systems Dominate Apheresis Equipment Market
-  Neurology - The Major Application Area for Apheresis Equipment
-  Developed Markets Continue to Lead Apheresis Equipment Market
-  Developing Nations to Lead the Charge in Future
-  Rising Demand for Plasma from Biopharmaceutical Companies
-  Opportunity to Tap
-  Sustained Growth in Blood Collections Favors Apheresis Equipment Market
-  Competitive Landscape
-  Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers

2. KEY MARKET TRENDS & DRIVERS
-  Rising Cancer Incidence to Drive Volume of Apheresis Procedures
-  Technological Advancements and Novel Indications Augur Well for Apheresis Market
-  Blood Supply Shortage & Safety Concerns Bode Well for Apheresis Market
-  Photopheresis: A Popular Therapeutic Apheresis Procedure
-  Plasmapheresis Continues to Lead the Apheresis Market
-  Plateletpheresis Emerges as the Treatment of Choice'
-  Increase in Number of Platelet Donors Drives Apheresis Procedures
-  Pediatrics: An Unexplored Domain in Therapeutic Apheresis
-  Automated Blood Processing Systems in Open Heart Surgeries
-  CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
-  Improving Healthcare Expenditure to Drive Demand
-  Aging Population: A Strong Growth Driver
-  Key Challenges & Issues
-  Lack of Awareness among Patients Restrains Market Growth
-  Vendors' Attitude Hampers Growth Prospects of Therapeutic Apheresis
-  Development of Inexpensive Apheresis Therapies
-  Shortage of Qualified Donors
-  Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment

3. TECHNOLOGY OVERVIEW
-  Apheresis - The Definition
-  Apheresis Vs Whole Blood Collection
-  Comparison of Apheresis and Whole Blood Collection
-  The Process of Apheresis - An Overview
-  Blood Components
-  Apheresis Procedure
-  Duration, Frequency, and Efficiency of Apheresis
-  Segregation of Blood Components
-  Centrifugation
-  Centrifugal Cell Separators
-  Filtration
-  Side Effects
-  Types of Apheresis Procedures
-  Plasmapheresis
-  Plasma Exchange and Plasmapheresis: The Difference
-  Therapeutic Plasma Exchange (TPE) or Plasma Exchange
-  TPE: Abnormal Components Removed from Blood
-  Plasmapheresis: Potential Uses Discovered in the Early Years
-  Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
-  Erythrocytapheresis
-  Plateletpheresis
-  Leukapheresis
-  Photopheresis
-  Functioning of THERAKOS - A Typical Photopheresis System
-  Lipidpheresis
-  Cytapheresis
-  Stem Cell Collection
-  Apheresis - A Review of Segmentation
-  Donor Apheresis
-  Process of Donor Apheresis
-  Automated Blood Donation Procedures
-  Safety of the Donor
-  Blood Components Required by Different Patients
-  Automated Apheresis
-  Therapeutic Apheresis: An Introduction
-  Therapeutic Apheresis Techniques
-  Applications of Therapeutic Apheresis
-  Categories of Indications for Therapeutic Apheresis
-  Therapeutic Apheresis is Remedial for Various Diseases
-  Indications for Therapeutic Apheresis
-  Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
-  Emerging Applications of Therapeutic Apheresis
-  Cost of Select Therapeutic Apheresis Procedures: An Overview
   1. Photopheresis in GVHD (Graft-Versus-Host Disease)
   2. Lipid Apheresis (LDL Apheresis)
   3. Plasmapheresis and Other Procedures
-  Therapeutic Apheresis: What is the Risk Involved?
-  Replacement Fluid in Therapeutic Apheresis
-  Replacement Fluids Used in Therapeutic Apheresis
-  Various Replacement Fluids in Use
-  Select Replacement Fluids and their Limitations
-  Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
-  Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement

4. BLOOD COMPONENTS & DERIVATIVES
-  Red Blood Cells (RBCs)
-  White Blood Cells (WBCs)
-  Platelets
-  Sources of Blood Plasma
-  Facts About Plasma and its Donation
-  Pre-requisites for Plasma Donors
-  The Complex Process of Becoming a Donor
-  Medical Screening
-  The Process of Plasma Donation
-  Select IQPP-authorized Plasma Collection Centers (US)
-  Ionic Composition of Blood
-  Types of Blood
-  General Facts about Blood
-  General Uses of Blood
-  Blood - Global Facts

5. PRODUCT INNOVATIONS/INTRODUCTIONS
-  Fresenius Introduces 6008 CAREsystem
-  Terumo BCT Launches Correct Connect System
-  FDA Approves IDE Supplement for Cerus' INTERCEPT Blood System
-  Health Canada Approves WBCD and PMN Cell Collection Protocols for Spectra Optia
-  USFDA Clears PMN Protocol for Terumo's Spectra Optia

6. RECENT INDUSTRY ACTIVITY
-  Haemonetics Gains FDA Approval for NexSys PCS Plasmapheresis System
-  Terumo BCT Receives CE Mark for Spectra Optia Apheresis System
-  Terumo BCT Enters into Distribution Agreement with B Medical Systems
-  Mallinckrodt Takes Over Therakos
-  HemaCare Sells Therapeutic Apheresis Assets to Fresenius
-  Terumo BCT Files FDA Submission to Improve Blood Supply Safety
-  Fenwal Autopheresis-C Instruments Donated for Ebola Virus Study
-  Terumo opens Production Facility in Vietnam
-  Terumo Collaborates with Kaneka
-  Terumo to Distribute Therakos Products in Latin America
-  Terumo Enters Distribution Agreement with Therakos

7. FOCUS ON SELECT PLAYERS
-  Asahi Kasei Medical Co., Ltd. (Japan)
-  B Braun Melsungen AG (Germany)
-  Cerus Corporation (USA)
-  Fresenius Kabi (Germany)
-  Haemonetics Corporation (USA)
-  Kaneka Corporation (Japan)
-  Kawasumi Laboratories, Inc. (Japan)
-  Mallinckrodt Pharmaceuticals (Ireland)
-  Medica SpA (Italy)
-  NIKKISO Europe GmbH (Germany)
-  Terumo BCT, Inc. (USA)

8. GLOBAL MARKET PERSPECTIVE

For more information about this report visit https://www.researchandmarkets.com/research/mc4r97/apheresis

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets